Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Ohlstein

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Pharmacology|January 1, 1989
Selective inhibition of endothelium-dependent relaxation by gold-containing compoundsE H Ohlstein, S Horohonich
Journal of Cardiovascular Pharmacology|January 1, 1984
Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptorB A Berkowitz, E H Ohlstein
Journal of Neurosurgery|August 1, 1992
Oxyhemoglobin stimulation of endothelin production in cultured endothelial cellsE H Ohlstein, B L Storer
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Stimulation of vascular dopamine receptors: status and future strategiesB A Berkowitz, E H Ohlstein
European Journal of Pharmacology|January 22, 1985
SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptorsE H Ohlstein, B A Berkowitz
Trends in Cardiovascular Medicine|April 3, 2001
Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular diseaseS A Douglas, E H Ohlstein
Circulation Research|October 1, 1989
Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscleE H Ohlstein, A J Nichols
Hypertension (Dallas, Tex. : 1979)|March 1, 1985
Cyclic guanosine monophosphate mediates vascular relaxation induced by atrial natriuretic factorE H Ohlstein, B A Berkowitz
Journal of Vascular Research|May 1, 1997
Signal transduction mechanisms mediating the vascular actions of endothelinS A Douglas, E H Ohlstein
Journal of Cardiovascular Pharmacology|January 1, 1993
Endothelin-1 promotes neointima formation after balloon angioplasty in the ratS A Douglas, E H Ohlstein
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Pharmacology|January 1, 1989
Selective inhibition of endothelium-dependent relaxation by gold-containing compoundsE H Ohlstein, S Horohonich
Journal of Cardiovascular Pharmacology|January 1, 1984
Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptorB A Berkowitz, E H Ohlstein
Journal of Neurosurgery|August 1, 1992
Oxyhemoglobin stimulation of endothelin production in cultured endothelial cellsE H Ohlstein, B L Storer
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Stimulation of vascular dopamine receptors: status and future strategiesB A Berkowitz, E H Ohlstein
European Journal of Pharmacology|January 22, 1985
SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptorsE H Ohlstein, B A Berkowitz
Trends in Cardiovascular Medicine|April 3, 2001
Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular diseaseS A Douglas, E H Ohlstein
Circulation Research|October 1, 1989
Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscleE H Ohlstein, A J Nichols
Hypertension (Dallas, Tex. : 1979)|March 1, 1985
Cyclic guanosine monophosphate mediates vascular relaxation induced by atrial natriuretic factorE H Ohlstein, B A Berkowitz
Journal of Vascular Research|May 1, 1997
Signal transduction mechanisms mediating the vascular actions of endothelinS A Douglas, E H Ohlstein
Journal of Cardiovascular Pharmacology|January 1, 1993
Endothelin-1 promotes neointima formation after balloon angioplasty in the ratS A Douglas, E H Ohlstein
Pageof 17